| Entry |
|
|---|
| Name |
Dacarbazine citrate |
|---|
| Formula |
C6H8O7. C6H10N6O
|
|---|
| Exact mass |
374.1186
|
|---|
| Mol weight |
374.31
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01677 Alkylating agent
|
|---|
| Remark |
| Product (DG00680): | D00288<JP/US> |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Target |
DNA
RNA |
|---|
| Interaction |
|
|---|
| Structure map |
| map07040 | Antineoplastics - alkylating agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AX Other alkylating agents
L01AX04 Dacarbazine
D07772 Dacarbazine citrate
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG00680 Dacarbazine
D07772 Dacarbazine citrate
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG00680 Dacarbazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 C8y C 21.0732 -6.8628
2 C8y C 21.0732 -8.2631
3 N5x N 22.4034 -8.6831
4 C8x C 23.2435 -7.5630
5 N4x N 22.4034 -6.4428
6 N2b N 19.8830 -6.1627
7 N2b N 18.6228 -6.8628
8 N1a N 18.6228 -8.2631
9 C5a C 19.8830 -8.9632
10 O5a O 19.8830 -10.3634
11 N1c N 17.4326 -6.1627
12 C1a C 16.2424 -6.8628
13 C1a C 17.4326 -4.7625
14 C1d C 29.8200 -7.0000
15 C1b C 28.6300 -7.7000
16 C1b C 31.0100 -7.7000
17 C6a C 30.5200 -5.8100
18 O1a O 29.1200 -5.8100
19 C6a C 27.4400 -7.0700
20 C6a C 31.0100 -9.1000
21 O6a O 29.8200 -4.6200
22 O6a O 31.9200 -5.8100
23 O6a O 26.1800 -7.7700
24 O6a O 27.4400 -5.6700
25 O6a O 32.2700 -9.8000
26 O6a O 29.8200 -9.8000
BOND 25
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 1 5 1
6 1 6 1
7 6 7 2
8 8 9 1
9 2 9 1
10 9 10 2
11 7 11 1
12 11 12 1
13 11 13 1
14 14 15 1
15 14 16 1
16 14 17 1
17 14 18 1
18 15 19 1
19 16 20 1
20 17 21 1
21 17 22 2
22 19 23 1
23 19 24 2
24 20 25 1
25 20 26 2
|
|---|
